There’s an epidemic of low-muscle mass that deserves more attention.
It has long been known that muscle weakness (e.g. poor grip strength) is correlated with shortened lifespan and all-cause mortality.
But a recent analysis in breast cancer patients and people with heart disease predicted a poorer prognosis in those with low muscle mass compared to high muscle mass.
Sponsored:
Support your Workout Sessions and Healthy Hydration with this Creatine Electrolyte Combo by MYOXCIENCE
Save 12% with code podcast at checkout
References:
Key Takeaways:
00:36 Muscle enhances survivability from chronic disease.
01:10 There was a significant survival benefit from higher quantities of muscle. In chronic kidney disease.
02:00 Resistance training enhances longevity and prevents a variety of disease states.
02:10 Independent of fat mass, survival was higher in those with higher muscle mass.
02:45 Lower muscle mass reflected a worse survival rate in dialysis patients.
03:30 A sudden drop in albumin is an ominous marker, indicating lower survival rates.
07:20 Sarcopenia is found in 14% of breast cancer patients and 1 in 3 had pre-sarcopenia.
08:30 People with low muscle mass have a higher toxicity associated with chemotherapy drugs and have worse outcomes.
10:02 We need to prioritize protein, sleep, recovery, and intense physical activity that involves resistance training.
10:50 Loss of lean mass better predicts a cardiovascular event compared to fat gain.
0 comments